000			03072nam a22003977a 4500
008			220511s20222022 xxu||||| |||| 00| 0 eng d
022			_a1878-0938
024			_a10.1016/j.carrev.2022.03.005 [doi]
024			_aS1553-8389(22)00116-6 [pii]
040			_aOvid MEDLINE(R)
099			_a35337755
245			_aImpact of migraine headaches on stress induced 'Takotsubo' cardiomyopathy.
251			_aCardiovascular Revascularization Medicine. 2022 Mar 14
252			_aCardiovasc Revasc Med. 2022 Mar 14
253			_aCardiovascular revascularization medicine : including molecular interventions
260			_c2022
260			_fFY2022
260			_p2022 Mar 14
265			_saheadofprint
266			_d2022-05-11
520			_aCONCLUSIONS: TCM patients with migraines were found to have a better outcome and mortality. They had significantly fewer complications (cardiac arrest, heart failure exacerbation, intubation, acute kidney injury). Copyright © 2022 Elsevier Inc. All rights reserved.
520			_aINTRODUCTION: Takotsubo cardiomyopathy (TCM) is an acute left ventricular dysfunction, typically due to a neuro-cardiogenic mechanism. Although many stressors can precipitate TCM, the role of migraines in hospitalized TCM patients has not been studied. Our objective is to describe the in-hospital outcomes of TCM in patients with a concurrent diagnosis of migraines.
520			_aMETHODS: We conducted a US-wide analysis of TCM hospitalizations from 2013 to 2017 by querying the National Inpatient Sample database for the International Classification of Diseases-ninth Revision. Patients admitted with a principal diagnosis of TCM with a history of migraines were identified using the ICD-10 codes. TCM patients with migraines were then compared to TCM patients without migraines regarding mortality and acute inpatient complications (intubation, cardiac arrest, heart failure exacerbation, acute kidney injury). A logistic regression model was constructed to account for potential confounders.
520			_aRESULTS: A total of 172,025 TCM patients were identified. Of those patients, 3610 suffered from migraines. TCM patients with a diagnosis of migraine were associated with a lower odds for mortality (OR: 0.388; [0.311-0.485]; p < 0.001) and acute complications (OR: 0.511 [0.471-0.554]; p < 0.001) compared to those without migraines. After adjusting for confounders, the adjusted odds ratio for mortality was 0.622; [0.495-0.782]; p < 0.001, and acute complications were 0.563 [0.519-0.611]; p < 0.001.
546			_aEnglish
650			_aIN PROCESS -- NOT YET INDEXED
651			_aMedStar Heart & Vascular Institute
651			_aMedStar Washington Hospital Center
656			_aInternal Medicine Residency Joseph
657			_aJournal Article
700			_aGarcia-Garcia, Hector M
700			_aVarghese, Jobin
790			_aFrances BS, Garcia-Garcia HM, Varghese JJ, Yacob O
856			_uhttps://dx.doi.org/10.1016/j.carrev.2022.03.005 _zhttps://dx.doi.org/10.1016/j.carrev.2022.03.005
942			_cART _dArticle
999			_c597 _d597